Aqtual, Inc. Alternatives & Competitors
12 companies similar to Aqtual, Inc. — Advancing Precision Medicine Products in the Costliest Disease Areas through a N...
Companies similar to Aqtual, Inc.
Blue Cell Therapeutics
We are dedicated to develop novel stem cell therapies to treat chronic diseases
Denmark
Orum Therapeutics
A public biotechnology company pioneering a novel class of protein degraders.
Lexington, United States
Jasper Therapeutics
Jasper is a biotechnology company focused on targeting mast cells and stem cells to treat...
Redwood City, United Stat...
Mersana Therapeutics
Our mission is to discover and develop life-changing antibody-drug conjugates (ADCs) for p...
Cambridge, United States
Track all Aqtual, Inc. competitors
Get real-time alerts when any of these companies raise funding, hire, or show growth signals.
Neogene Therapeutics
Pushing the frontier by pioneering next-generation engineered T cell receptor therapies fo...
Amsterdam, The Netherland...
Faeth Therapeutics
Unlocking the power of metabolism to treat cancer.
United States
HepaRegeniX GmbH
Unlocking liver regeneration - delivering recovery
Tubingen, Germany
Parallel Bio
Using the immune system to cure disease.
Watertown, United States
Upstream Bio
Developing treatments for inflammatory diseases
Waltham, United States
Avidity Biosciences, Inc.
At Avidity, we are developing a new class of oligonucleotide-based therapies.
San Diego, United States
SynOx Therapeutics
Our mission is to focus on the unmet clinical needs of patients suffering from Tenosynovi...
Ireland
Avenzo Therapeutics
Developing the next generation of oncology therapies for patients
San Diego, United States
About Aqtual, Inc.
Aqtual, Inc., founded in 2019, is at the forefront of transforming the landscape of precision medicine. Focusing on the biotechnology sector, the company operates within the expansive domains of Biotechnology, Health and Wellness, and Machine Learning. Headquartered in the United States, Aqtual leverages a novel cell-f...
Revolutionizing chronic disease and oncology management, Development of blood tests for disease detection and monitoring, Bridging research and practical healthcare solutions, Creating a catalog of disease-specific clinical features
Healthcare providers, Patients with chronic inflammatory conditions, Oncology patients, Medical researchers, Pharmaceutical companies
Precision Medicine, Cell-Free DNA Platform, Chronic Diseases, Oncology, Healthcare Solutions, Translational Research, Innovation, Clinical Diagnostics
B2B2C, Platform, SaaS
Product Sales, Licensing, Data Monetization
Frequently Asked Questions
Don't just read about them. Follow them.
BounceWatch watches Aqtual, Inc. and millions of other companies. When one raises money, hires quickly or changes its product, we tell you the same day.
Compiled from the BounceWatch company index. We last looked at Aqtual, Inc. on 12 Sep 2024. The 12 companies listed here were last checked between 11 Sep 2024 and 11 Jun 2026. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.
